Spruce Biosciences Inc. (NASDAQ: SPRB)
$0.59
+0.0103 ( +1.78% ) 510.4K
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Market Data
Open
$0.59
Previous close
$0.58
Volume
510.4K
Market cap
$24.28M
Day range
$0.58 - $0.60
52 week range
$0.50 - $5.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 18, 2024 |
8-k | 8K-related | 11 | Jun 03, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
4 | Insider transactions | 1 | May 24, 2024 |
8-k | 8K-related | 11 | May 24, 2024 |